跳至主要内容
临床试验/EUCTR2016-002255-25-DK
EUCTR2016-002255-25-DK进行中(未招募)1 期

Electrochemotherapy versus standard radiatiotherapy for the treatment of basal cell carcinoma

Department of Oncology, Herlev Hospital0 个研究点目标入组 52 人开始时间: 2016年6月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Age > 18
  • 2. Patients should understand participants information
  • 3. Histologically confirmed basal cell carcinoma
  • 4. Signed informed constent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • 1. Prior treatment with bleomycin above 200.000 Units/m2
  • 2. Prior radiotherapy to the same area

研究者

发起方
Department of Oncology, Herlev Hospital

相似试验

进行中(未招募)
1 期
Electrochemotherapy versus conventional surgery in treatment of basal cell carcinomaBasal cell carcinoma of the skinMedDRA version: 12.1Level: LLTClassification code 10004146Term: Basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10004148Term: Basal cell carcinoma excisionMedDRA version: 12.1Level: LLTClassification code 10004149Term: Basal cell carcinoma skin excisionMedDRA version: 12.1Level: LLTClassification code 10024542Term: Lip basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10027492Term: Metatypical basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10027981Term: Morpheaform basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10029496Term: Nodulo-ulcerative basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10035029Term: Pigmented basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10039716Term: Sclerosing basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10042503Term: Superficial basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10062787Term: Morphoeaform basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10064679Term: Basal cell carcinoma of skin in situMedDRA version: 12.1Level: PTClassification code 10004146Term: Basal cell carcinoma
EUCTR2010-019260-37-IECork Cancer Research Centre100
进行中(未招募)
不适用
Electrochemotherapy as a palliative treatment for brain metastasesPatient with brain metastases from cancer of any histology. A phase I trial.MedDRA version: 12.1Level: LLTClassification code 10006128Term: Brain metastases
EUCTR2010-023356-90-DKOncology Department18
招募中
2 期
Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial (ECT-HN)
2025-520735-16-00IRCCS Istituto Nazionale Tumori Fondazione Pascale96
进行中(未招募)
1 期
Electrochemotherapy versus narrow excision margins for high-risk, primary cutaneous melanoma
EUCTR2018-003531-30-ITISTITUTO NAZIONALE TUMORI - IRCCS FONDAZIONE PASCALE220
终止
1 期
Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver MetastasesColorectal Adenocarcinoma
NCT02709811IGEA5